Skeletal muscle cell protein dysregulation highlights the pathogenesis mechanism of myopathy-associated p97/VCP R155H mutations
Anna Luzzi(UCLA Medical Center), Tsui‐Fen Chou(California Institute of Technology)
Cited by 1
Related Papers
Reversible inhibitor of p97, DBeQ, impairs both ubiquitin-dependent and autophagic protein clearance pathways
|Proceedings of the National Academy of Sciences|2011|323